A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation

Anaesthesia

Volumn 65, Issue 3, 2010, Pages 254-259

  Tsai, C J ^a   Chu, K S ^a   Chen, T I ^a   Lu, D V ^a   Wang, H M ^b   Lu, I Cheng ^a  

^a Department of Otorhinolaryngology Head and Neck Surgery   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; LIDOCAINE; PROPOFOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; FIBEROSCOPE; HEART RATE; HUMAN; HYPOXIA; LOADING DRUG DOSE; MALE; MEAN ARTERIAL PRESSURE; NASOTRACHEAL INTUBATION; PATIENT ATTITUDE; SCORING SYSTEM; SEDATION; SIDE EFFECT;

ADULT; BLOOD PRESSURE; CONSCIOUS SEDATION; DEXMEDETOMIDINE; FEMALE; FIBER OPTIC TECHNOLOGY; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTUBATION, INTRATRACHEAL; MALE; MIDDLE AGED; NASAL CAVITY; PROPOFOL;

EID: 76649087028     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2009.06226.x     Document Type: Article

References (21)

1. Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesthesia and Analgesia 2009; 108: 852-7.
2. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil target-controlled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. British Journal of Anaesthesia 2008; 100: 125-30.
3. Stamenkovic DM, Hassid M. Dexmedetomidine for fiberoptic intubation of a patient with severe mental retardation and atlantoaxial instability. Acta Anaesthesiologica Scandinavica 2006; 50: 1314-5.
4. Machata AM, Gonano C, Holzer A, et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesthesia and Analgesia 2003; 97: 904-8.
5. Knolle E, Oehmke MJ, Gustorff B, Hellwagner K, Kress HG. Target-controlled infusion of propofol for fibreoptic intubation. European Journal of Anaesthesiology 2003; 20: 565-9.
6. Kamibayashi T, Maze M. Clinical uses of alpha2 -adrenergic agonists. Anesthesiology 2000; 93: 1345-9.
7. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesthesia and Analgesia 2000; 90: 699-705.
8. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. Journal of Clinical Anesthesia 2007; 19: 370-3.
9. Maroof M, Khan RM, Jain D, Ashraf M. Dexmedetomidine is a useful adjunct for awake intubation. Canadian Journal of Anaesthesia 2005; 52: 776-7.
10. Jooste EH, Ohkawa S, Sun LS. Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements. Anesthesia and Analgesia 2005; 101: 1248.
11. Chu KS, Wang FY, Hsu HT, Lu IC, Wang HM, Tsai CJ. The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation. European Journal of Anaesthesiology 2010; 27: 36-40.
12. Schnider TW, Minto CF, Gambus PL, et al. The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170-82.
13. Puchner W, Egger P, Puhringer F, Lockinger A, Obwegeser J, Gombotz H. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiologica Scandinavica 2002; 46: 350-4.
14. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. Journal of Clinical Anesthesia 2007; 19: 141-4.
15. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54: 1136-42.
16. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77: 1125-33.
17. Yavascaoglu B, Kaya FN, Baykara M, Bozkurt M, Korkmaz S. A comparison of esmolol and dexmedetomidine for attenuation of intraocular pressure and haemodynamic responses to laryngoscopy and tracheal intubation. European Journal of Anaesthesiology 2008; 25: 517-9.
18. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77: 1134-42.
19. Aantaa R, Kanto J, Scheinin M, Kallio A, Scheinin H. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990; 73: 230-5.
20. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93: 382-94.
21. Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and perioperative haemodynamic stability. Anaesthesia 1997; 52: 736-44.